Trial of Nab-Sirolimus for patients with malignant solid tumors with TSC1 or TSC2 alterations

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (TSC-007)

Disease Types: Solid Tumors

Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (TSC-007)

For More Information:

https://clinicaltrials.gov/ct2/show/NCT05103358?term=A+Phase+2+multi-center+open-label+basket+trial+of+nab-sirolimus+for+adult+and+adolescent+patients+with+malignant+solid+tumors+harboring+pathogenic+inactivating+alterations+in+TSC1+or+TSC2+genes+%28TSC-007%29&draw=2&rank=1